Daiwa Securities Group Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$03720.0%0.00%
Q2 2022$0
-100.0%
3720.0%0.00%
Q1 2022$1,0000.0%3720.0%0.00%
Q4 2021$1,0000.0%3720.0%0.00%
Q3 2021$1,000
-50.0%
3720.0%0.00%
Q2 2021$2,000
+100.0%
3720.0%0.00%
Q1 2021$1,0000.0%3720.0%0.00%
Q4 2020$1,000
-50.0%
372
-54.1%
0.00%
Q3 2020$2,000
+100.0%
8100.0%0.00%
Q2 2020$1,0000.0%8100.0%0.00%
Q1 2020$1,000
-50.0%
8100.0%0.00%
Q4 2019$2,0000.0%8100.0%0.00%
Q3 2019$2,0000.0%8100.0%0.00%
Q2 2019$2,0000.0%8100.0%0.00%
Q1 2019$2,0000.0%8100.0%0.00%
Q4 2018$2,000
-33.3%
8100.0%0.00%
Q3 2018$3,000
+50.0%
8100.0%0.00%
Q2 2018$2,000
-33.3%
8100.0%0.00%
Q1 2018$3,0008100.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders